Working capital increased 24.0%
Working capital changed +24.0% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$9.3M→$11.6M4 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →WRAP financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Current ratio increased 42.2%
Current ratio changed +42.2% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
5.65→8.044 prior comparisons
R&D / revenue moved 860 bp lower
R&D / revenue changed -860 basis points from the comparable as-filed period.
16.01%→7.41%3 prior comparisons
Working capital / assets moved 1564 bp higher
Working capital / assets changed +1564 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
59.69%→75.33%4 prior comparisons
Current liabilities decreased 18.0%
Current liabilities changed -18.0% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$2.0M→$1.6M4 prior comparisons
Current assets increased 16.6%
Current assets changed +16.6% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$11.3M→$13.2M4 prior comparisons
Receivables / revenue moved 7509 bp higher
Receivables / revenue changed +7509 basis points from the comparable as-filed period.
89.53%→164.62%3 prior comparisons
Free-cash-flow margin moved 7343 bp higher
Free-cash-flow margin changed +7343 basis points from the comparable as-filed period.
-192.29%→-118.86%3 prior comparisons
Operating cash-flow margin moved 7313 bp higher
Operating cash-flow margin changed +7313 basis points from the comparable as-filed period.
-191.70%→-118.57%3 prior comparisons
Selling, general & administrative increased 14.6%
Selling, general & administrative changed +14.6% from the comparable as-filed period.
$3.2M→$3.6M3 prior comparisons
Shares outstanding increased 10.2%
Shares outstanding changed +10.2% from the comparable as-filed period.
50,820,698→56,003,6383 prior comparisons
Research & development decreased 6.2%
Research & development changed -6.2% from the comparable as-filed period.
$162,000→$152,0003 prior comparisons
Total assets decreased 1.7%
Total assets changed -1.7% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$15.6M→$15.3M4 prior comparisons
Capex / revenue moved 30 bp lower
Capex / revenue changed -30 basis points from the comparable as-filed period.
0.59%→0.29%3 prior comparisons
Cost of revenue decreased 3.4%
Cost of revenue changed -3.4% from the comparable as-filed period.
$525,000→$507,0003 prior comparisons
Capital expenditure unchangedd 0.0%
Capital expenditure changed +0.0% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$6,000→$6,0004 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.